Sequence announces our new website and logo

Read
All Projects

Global Operating System Upgrade & Analytical Instrument Validation

Biologics

Client Overview

Biogen Inc. is a biopharmaceutical company that focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases.

Sequence Scope

To ensure security and business continuity, the client requested a plan for a multi-site, global QC Operating System (OS) update of all their lab systems to a single platform. Validation services were required to ensure compliance and data integrity of each system being upgraded. Sequence generated validation lifecycle documentation for over 80+ lab systems across 3 sites (Cambridge, RTP, and Denmark), including project management services and strategic testing strategies for global harmonization. The team performed reviews of software configuration and provided recommendations for compliance with 21CFR11 & Eudralex requirements, while ensuring all operational and functional requirements are met. The scope also included support for data backup process and system integration to NuGenesis. The project was completed as scheduled.

Life Impact

  • Biogen is making advancements in pharmaceutical manufacturing and medical research programs. Its active research includes treatments for conditions like multiple sclerosis, spinal muscular atrophy and other serious neurological conditions.

Get Started

How can we support your project success?

Contact Us
855.844.7171 info@sequenceQCS.com
  • Global Headquarters
    2100 Gateway Center Blvd, Suite 301
    Morrisville, NC 27560

  • Lab and Training Center
    2500 Gateway Center Blvd, Suite 850
    Morrisville, NC 27560

  • Northeast Office
    1 Speen Street, Suite 120
    Framingham, MA 01701

Sign up for our email newsletter

Accelerating time to market through proven quality and compliance solutions.

© 2021 Sequence, Inc. All rights reserved.